Literature DB >> 17662279

Ultrasonographic characteristics of the endometrium among patients with fibroids undergoing ART.

Eric D Levens1, Barbara J Stegmann, Eve C Feinberg, Frederick W Larsen.   

Abstract

A retrospective cohort study examining all completed nondonor first ART cycles was performed to evaluate the ultrasonographic appearance of the endometrial pattern and thickness at time of hCG administration among precycle screened patients with uterine fibroids compared with patients without fibroids. There was no difference in the endometrial thickness (10.3 +/- 2.0 mm vs. 10.0 +/- 2.6 mm) between those with fibroids and controls; however, the rate of nonproliferative endometrial pattern (3.1% vs. 1.0%) and live birth rates (34.4% vs. 43.0%) were significantly different, most notably among those patients with intramural fibroids.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17662279      PMCID: PMC2394501          DOI: 10.1016/j.fertnstert.2007.03.096

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  20 in total

1.  The detrimental effect of increased endometrial thickness on implantation and pregnancy rates and outcome in an in vitro fertilization program.

Authors:  A Weissman; L Gotlieb; R F Casper
Journal:  Fertil Steril       Date:  1999-01       Impact factor: 7.329

2.  Endometrial pattern on the day of oocyte retrieval is more predictive of implantation success than the pattern or thickness on the day of hCG administration.

Authors:  F I Sharara; J Lim; H D McClamrock
Journal:  J Assist Reprod Genet       Date:  1999-11       Impact factor: 3.412

3.  Evaluation of endometrial receptivity during in-vitro fertilization using three-dimensional power Doppler ultrasound.

Authors:  I Y Järvelä; P Sladkevicius; S Kelly; K Ojha; S Campbell; G Nargund
Journal:  Ultrasound Obstet Gynecol       Date:  2005-12       Impact factor: 7.299

4.  Effect of myomectomy on the outcome of assisted reproductive technologies.

Authors:  Eric S Surrey; Debra A Minjarez; John M Stevens; William B Schoolcraft
Journal:  Fertil Steril       Date:  2005-05       Impact factor: 7.329

5.  Uterine myomata and outcome of assisted reproduction.

Authors:  A M Ramzy; M Sattar; Y Amin; R T Mansour; G I Serour; M A Aboulghar
Journal:  Hum Reprod       Date:  1998-01       Impact factor: 6.918

6.  Increased endometrial thickness is associated with improved treatment outcome for selected patients undergoing in vitro fertilization-embryo transfer.

Authors:  Xingqi Zhang; Chi-Huang Chen; Edmond Confino; Randall Barnes; Magdy Milad; Ralph R Kazer
Journal:  Fertil Steril       Date:  2005-02       Impact factor: 7.329

7.  Endometrial receptivity in an in vitro fertilization program as assessed by spiral artery blood flow, endometrial thickness, endometrial volume, and uterine artery blood flow.

Authors:  R L Schild; C Knobloch; C Dorn; R Fimmers; H van der Ven; M Hansmann
Journal:  Fertil Steril       Date:  2001-02       Impact factor: 7.329

8.  Comparison of assisted reproductive technology utilization and outcomes between Caucasian and African American patients in an equal-access-to-care setting.

Authors:  Eve C Feinberg; Frederick W Larsen; William H Catherino; Jun Zhang; Alicia Y Armstrong
Journal:  Fertil Steril       Date:  2006-03-09       Impact factor: 7.329

9.  Effect of intramural, subserosal, and submucosal uterine fibroids on the outcome of assisted reproductive technology treatment.

Authors:  T Eldar-Geva; S Meagher; D L Healy; V MacLachlan; S Breheny; C Wood
Journal:  Fertil Steril       Date:  1998-10       Impact factor: 7.329

10.  Effects of myomas or prior myomectomy on in vitro fertilization (IVF) performance.

Authors:  M A Seoud; R Patterson; S J Muasher; C C Coddington
Journal:  J Assist Reprod Genet       Date:  1992-06       Impact factor: 3.412

View more
  1 in total

Review 1.  Is Myomectomy Prior to Assisted Reproductive Technology Cost Effective in Women with Intramural Fibroids?

Authors:  Mary Ojo-Carons; Sunni L Mumford; Alicia Y Armstrong; Alan H DeCherney; Kate Devine
Journal:  Gynecol Obstet Invest       Date:  2016-03-19       Impact factor: 2.031

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.